Evaluation of Plasmodium falciparum MSP10 and its development as a serological tool for the Peruvian Amazon region

Background Different antigens are needed to characterize Plasmodium falciparum infection in terms of seroreactivity and targets for invasion inhibition, in order to guide and identify the proper use of such proteins as tools for the development of serological markers and/or as vaccine candidates.